(Q46302480)

21 December 2017

title

Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region (English)

1 reference

21 December 2017

Papillomavirus infections

main subject

1 reference

D Maxwell Parkin

1

1 reference

21 December 2017

Karly S Louie

series ordinal

2

1 reference

21 December 2017

Gary Clifford

series ordinal

3

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

21 December 2017

published in

Vaccine

1 reference

21 December 2017

volume

26 Suppl 12

1 reference

21 December 2017

page(s)

M1-16

1 reference

21 December 2017

Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus infection and cervical cancer prevention in Japan and Korea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Geographic pathology revisited: development of an atlas of cancer in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Cancer incidence in Western Samoa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Cancer incidence trends in urban shanghai, 1972-1994: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Trends in the incidence of cancer in Qidong, China, 1978-2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Trends in cervical cancer mortality in Korea 1993-2002: corrected mortality using national death certification data and national cancer incidence data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Time trends in cancer mortality in China: 1987-1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Predicting the future burden of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Cancer in Chiang Mai, North Thailand. A Relative Frequency Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Cancer in the population of Hanoi, Vietnam, 1988-1990

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Results of clinically downstaging cervical cancer in a cytological screening programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Genital human papillomavirus infections in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Sex in Australia: sexually transmissible infection and blood-borne virus history in a representative sample of adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Correlates of sexually transmitted infections in young Australian women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Sexual health problems managed in Australian general practice: a national, cross sectional survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Is genital human papillomavirus infection always sexually transmitted?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Detection of human papillomavirus types in cervical lesions of patients from Taiwan by the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Correlates and trend of HIV prevalence among female sex workers attending sexually transmitted disease clinics in Pune, India (1993-2002).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Dermatologic manifestations among human immunodeficiency virus patients in south India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Multiple condom use and decreased condom breakage and slippage in Thailand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

HIV infection and risk factors among female sex workers in southern Vietnam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

HIV, sexually transmitted infections, and risk behaviours in male commercial sex workers in Sydney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Sexually transmitted infections and risk behaviours in women who have sex with women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human Papillomavirus Type Distribution in Cervical Cancer in Delhi, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus genotype in cervical cancer: a population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus genotyping using HPV DNA chip analysis in Korean women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Epidemiological study in Okinawa, Japan, of human papillomavirus infection of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus genotypes associated with cervical neoplasia in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast Thailand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Associations of high-risk HPV types and viral load with cervical cancer in China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: A Taiwan Cooperative Oncologic Group Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Type-specific distribution of human papillomavirus in relation to grades of cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

International correlation between human papillomavirus prevalence and cervical cancer incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

New technologies in cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.010

10.1016/J.VACCINE.2008.05.010

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017